AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
41 hedge funds and large institutions have $12.5M invested in AVEO Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 44 → 41 (-3)
29% less capital invested
Capital invested by funds: $17.6M → $12.5M (-$5.08M)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
59% less call options, than puts
Call options by funds: $13K | Put options by funds: $32K
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 2 |
Renaissance Technologies
New York
|
+$118K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.3K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$5.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$160K |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$87K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$75.8K |
| 4 |
Morgan Stanley
New York
|
-$39.2K |
| 5 |
Goldman Sachs
New York
|
-$24K |
AVEO Hedge Fund Activity: Q1 2016 in Review
41 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2016, worth a combined $12.5M — down 29% from $17.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AVEO and 1 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $120K. The largest seller was Spark Investment Management, exiting entirely with an estimated $160K sold.
- 41 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2016, down from 44 in Q4 2015.
- Funds reported $12.5M of AVEO Pharmaceuticals, Inc. stock for Q1 2016, down 29% quarter-over-quarter.
- 1 fund opened new AVEO Pharmaceuticals, Inc. positions in Q1 2016 and 4 closed out, a net change of -3 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2016 was Vanguard Group, an estimated $120K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q1 2016 was Spark Investment Management, an estimated $160K sold.
Based on aggregated 13F filings for Q1 2016.